1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 29 FEBRUARY 2016

CNS Drug News 29 FEBRUARY 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Breakthrough Designation Affirms Ocrelizumab Blockbuster Potential
Industry Brief - LCT Completes Private Placement Of Shares
Industry Brief - Xadago Launched In Spain To Treat Mid- To Late-Stage PD
Industry Trend Analysis - Open Innovation Tools Crucial For Parkinson's Disease Therapy Advancement
Industry Trend Analysis - Billion Dollar Revenues Beckoning For Impax
Industry Brief - ANI And Dexcel Gain Donepezil Approval
Industry Trend Analysis - US Investment Lays MTP Global Expansion Groundwork
Industry Brief - Retrophin's RE-024 Granted European ODD To Treat PKAN
Industry Brief - MultiStem Cell Therapy Phase II Stroke Study Yield Positive Results
Industry Trend Analysis - Novel Drug Delivery Techniques Could Aid MDD Development
Industry Brief - FDA Approves Impax' Mixed Amphetamines ANDA
Industry Brief - Alexza Regains Adasuve US Rights From Teva
Industry Brief - Lannett Gains Sumatriptan Nasal Spray Approval
Industry Brief - Dosing Begins In CAM2038 Phase II Study In Opioid Dependent Patients
Industry Brief - Belbuca Buccal Film Launched In US For Chronic Pain Management
Industry Brief - FDA Breakthrough Therapy Designation For Trevena's Oliceridine
Industry Brief - Adapt Pharma's Narcan Nasal Spray Now Available In US
Industry Brief - Aequus/Supernus Enter Licensing Deal For Trokendi/Oxtellar In Canada
Industry Trend Analysis - Briviact Approval Vital To Retain US Epilepsy Market Position
Industry Brief - Neurelis Finalises Funding To Advance NRL-1 NDA Filing
Industry Brief - FDA Approves Intellipharmaceutics' Levetiracetam
Industry Brief - E Keppra Granted Japanese Approval In Certain Generalised Tonic-Clonic Seizures Patients
Industry Trend Analysis - Mixed Trial Results Will Make Risk Management Key For Future Beloranib Development
Industry Brief - FDA ODD For Remedy's Cirara In Acute SAH/SCI
Industry Trend Analysis - Neuroscience IVDs Remain An Untapped Market
Industry Trend Analysis - Fresh Data Further Undermines Addyi Earnings Potential
Industry Trend Analysis - Rising Trial Risk Will Promote Novel Methods Of Drug Development
Industry Brief - Lightlake Changes Name To Opiant Pharmaceuticals

Table Of Contents

CNS Drug News 29 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.